Groundbreaking Work Changes Future for Ependymoma Research

Image. A word cloud with all words related to ependymoma, diagnosis and navigating brain tumor experiences.

CERN 08-02 Clinical Trial Creates Significant Impact in the Ependymoma Community

The CERN Foundation conducted a phase II clinical trial for adults with recurrent ependymoma called CERN 08-02 and the manuscript describing the results of the trial has been accepted into publication in Neuro-Oncology. The CERN 08-02 trial is the first prospective adult clinical trial to report on the potential use of chemotherapy for recurrent ependymoma in adults. Because of this study, this combination regimen has been endorsed by the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a standard treatment for adult patients with recurrent ependymoma.

Learn more.

An ijmage from the interview - Dallas and his caregiver, Janice, with Kim Wallgren.

NCI Connections Patient Spotlight

By Dallas

Ependymoma survivor, Dallas, and his family share how a rare brain tumor diagnosis impacts their life and the importance of partnering with their medical team to find the best care.

Watch Dallas's full story.

Support the Ependymoma Fund for Research and Education

We started 2020 with great anticipation that we would see significant advancements in neuro-oncology in this decade. And as we close 2020, we are confident that together, we will be a part of real change for people with ependymoma. Join us and make a year-end gift supporting the Ependymoma Fund for Research and Education.

With the holidays approaching, we welcome you to download this free printable butterfly gift tag or ornament that you can personalize to share with your loved ones. Be creative! Decorate your #CERNbutterfly!

Print Your Butterfly

The CERN Foundation and the National Brain Tumor Society have joined forces to help people with ependymoma and advance ependymoma research toward the development of new and better treatments through the creation of the Ependymoma Fund for Research and Education. Today, the CERN Foundation is officially a designated program of the National Brain Tumor Society. Donations to the Ependymoma Fund for Research and Education will be made on the NBTS website and used to support research efforts that will benefit both ependymoma patients and research through CERN. Emphasis will be placed on CERN’s historical model of supporting work that translates basic science into clinical practice. The Fund will also address overcoming barriers to clinical trial accrual and the development of new clinical studies for ependymoma patients. Additional funds will be used to support educational efforts through print, media, and awareness events. The new collaborative Ependymoma Fund will continue CERN’s practice and tradition of involving and collaborating with other scientists, medical providers, foundations and supporters of ependymoma research.

Friend us.

CERN Foundation PO Box 217 | Zionsville, IN 46077 US